Cabio Biotech (Wuhan) Co., Ltd.

SHSE:688089 주식 보고서

시가총액: CN¥3.6b

Cabio Biotech (Wuhan) 관리

관리 기준 확인 3/4

Cabio Biotech (Wuhan) CEO는 Dewei Yi, Dec2015 에 임명되었습니다 의 임기는 8.92 년입니다. 는 CN¥ 50.43M 가치에 해당하는 회사 주식의 1.39% 직접 소유합니다. 50.43M. 경영진과 이사회의 평균 재임 기간은 각각 8.9 년과 5.9 년입니다.

주요 정보

Dewei Yi

최고 경영자

CN¥1.1m

총 보상

CEO 급여 비율n/a
CEO 임기8.9yrs
CEO 소유권1.4%
경영진 평균 재임 기간8.9yrs
이사회 평균 재임 기간5.9yrs

최근 관리 업데이트

Recent updates

We Think That There Are Issues Underlying Cabio Biotech (Wuhan)'s (SHSE:688089) Earnings

Nov 04
We Think That There Are Issues Underlying Cabio Biotech (Wuhan)'s (SHSE:688089) Earnings

Cabio Biotech (Wuhan) (SHSE:688089) Might Be Having Difficulty Using Its Capital Effectively

Oct 28
Cabio Biotech (Wuhan) (SHSE:688089) Might Be Having Difficulty Using Its Capital Effectively

Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

Oct 01
Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Aug 06
There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Jun 07
Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

May 06
Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

May 03
Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

Mar 21
The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

CEO

Dewei Yi (59 yo)

8.9yrs

테뉴어

CN¥1,090,600

보상

Mr. Dewei Yi is Chairman and General Manager of CABIO Biotech(Wuhan) Co., Ltd., since December 2015. From December 1999 he has been the chairman of Wuhan Xiwang Biological Engineering Co., Ltd.; since Nove...


리더십 팀

이름위치테뉴어보상소유권
Dewei Yi
Chairman & GM8.9yrsCN¥1.09m1.39%
CN¥ 50.4m
Huabiao Wang
Financial Director & Director8.9yrsCN¥781.40k0.66%
CN¥ 24.0m
Huarong Yi
Deputy GM & Secretary of the Board of Directorsno dataCN¥640.10k0.089%
CN¥ 3.3m
Anfeng Geng
Deputy General Manager3.7yrsCN¥713.40k0.098%
CN¥ 3.6m
Zhiming Wang
Deputy General Manager2.9yrsCN¥862.90k0.14%
CN¥ 5.2m
Xiangyu Li
Deputy General Manager8.9yrsCN¥763.90k0.12%
CN¥ 4.4m
Tao Ma
Deputy General Manager8.9yrsCN¥640.90k0.093%
CN¥ 3.4m
Hao Xiong
Accounting Supervisorno data데이터 없음데이터 없음

8.9yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 관리: 688089 의 관리팀은 노련하고 경험 (평균 재직 기간 8.9 년)입니다.


이사회 구성원

이름위치테뉴어보상소유권
Dewei Yi
Chairman & GM8.9yrsCN¥1.09m1.39%
CN¥ 50.4m
Huabiao Wang
Financial Director & Director8.9yrsCN¥781.40k0.66%
CN¥ 24.0m
Bin Du
Vice Chairman8.9yrsCN¥984.80k0.58%
CN¥ 21.1m
Yujun Wu
Employee Representative Supervisor8.9yrs데이터 없음0.018%
CN¥ 661.5k
Chunyu Zhang
Director2.9yrs데이터 없음데이터 없음
Xiangdong Chen
Independent Director2.9yrsCN¥80.00k데이터 없음
Qi Liu
Independent Director2.9yrsCN¥80.00k데이터 없음
Jing Chen
Supervisor2.9yrs데이터 없음데이터 없음

5.9yrs

평균 재임 기간

53.5yo

평균 연령

경험이 풍부한 이사회: 688089 의 이사회경험(평균 재직 기간 5.9 년)으로 간주됩니다.